1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition Landscape
5.7 Upcoming trends
5.7.1 Market trends
5.7.2 Technological trends
5.7.3 Insurance & Regulations
5.7.4 Others
6. Global Chondrosarcoma Market by Types
6.1 Conventional chondrosarcoma
6.2 Clear cell chondrosarcoma
6.3 Myxoid chondrosarcoma
6.4 Mesenchymal chondrosarcoma
6.5 Dedifferentiated chondrosarcoma
6.6 Others
7. Global Chondrosarcoma Market by Diagnosis
7.1 Biopsy
7.1.1 Open Biopsy
7.1.2 Core Needle Biopsy
7.1.3 Others
7.2 Imaging
7.2.1 X-ray
7.2.2. Computed tomography scan (CT scan)
7.2.3 Magnetic resonance imaging (MRI)
7.2.4 Positron emission tomography (PET) scan
7.2.5 Others
7.3 Medication
7.3.1 Cinacalcet (Sensipar)
7.3.2 Sodium thiosulfate
7.3.3 Others
7.4 Surgery
7.4.1 Parathyroidectomy
7.4.2 Others
7.5 Adequate Pain Control
7.6 Clot-dissolving
7.6.1 Low-dose tissue plasminogen activator (TPA)
7.6.2 Others.
7.7 Others8. Global Chondrosarcoma Market by Treatment
8.1 Surgery
8.2 Therapies
8.2.1 Physical therapy
8.2.2 Radiation therapy
8.2.3 Chemotherapy
8.2.4 Others
8.3 Hemipelvectomy
8.3.1 External hemipelvectom
8.3.2 Internal hemipelvectomy
8.4 Others
9. Global Chondrosarcoma Market by End User
9.1 Hospitals and clinics
9.2 Medical Research centers
9.3 Academic institutes
9.4 Others
10. Global Chondrosarcoma Market by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 The US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of Asia
10.5 Pacific
10.6 Middle East and Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Egypt
10.6.4 Rest of Middle East and Africa
11. Competitive landscape
12. Company profile
13. Conclusion
13.1 Key findings
13.1.1 From CEO’s viewpoint
13.1.2 Unmet needs of the market
13.2 Key companies to watch
13.3 Prediction of Chondrosarcoma Market
14. Appendix
